BrainStorm Cell Therapeutics
Stem cell implantation shows beneficial effect on Parkinson disease
Published in Managed Care Business Week, November 22nd, 2005
The beneficial effect was retained for over 3 months. Worldwide rights to the development and commercialization of the new technology are exclusively licensed to BrainStorm.
The differentiated cells were previously shown to produce a unique protein required for brain cell survival and growth, glial cell line derived neurotrophic factor (GDNF). The GDNF expressing...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Business Week
More Articles from Managed Care Business Week
- Express Scripts, Inc.
Report claims Americans could have saved $20 billion in 2004 by using generics - Pennsylvania Office of the Governor
Pennsylvania governor says state is controlling medical malpractice costs - Triad Hospitals, Inc.
Triad Hospitals, Inc. reports $1.2 billion in revenues during third quarter 2005 - Verispan
Healthcare IT company releases web based interface for managed care software - A.I. Dupont Hospital for Children, Wilmington
Neonatal repair of tetralogy of Fallot results in improved pulmonary artery development - Academy of Military Medical Sciences, Beijing
Findings in cancer vaccines provide new insights - More from this issue of Managed Care Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
